Call 1-877-744-5675

How can we help?

How can we help?

 

Sign Up for the Co-Pay Savings Program

Select your medicine to find out if you’re eligible and to sign up for co-pay assistance.

Patient products webform

Note: The questions and fields below should be filled out by the patient. If you are a healthcare provider, click here to find out if your patient is eligible and to access a co-pay card.

Please answer the following eligibility questions:
Please enter your information:
Get text messages from your Care Champion!

*Required field.

Pfizer Oncology Together Co-Pay Program for IV

If you have commercial insurance, you may be eligible for the Pfizer Oncology Together Co-Pay Program for IV (“IV Co-Pay Program”). Limits, terms, and conditions apply.

Apply Today

To apply,|| download the enrollment form and fill out the required fields and the Intravenous (IV) Co-Pay Program section. This form requires some information from your healthcare provider, so it’s best to fill it out together.

enrollment form

For eligible, commercially insured patients

Your co-pay may be as little as $0. Once the annual program limit is reached, you are responsible for the full co-pay. #

$25,000 per calendar year

You could save up to $25,000|| per year on your medicine.

No income requirements

There are no income requirements to qualify.

||The IV Co-Pay Program provides assistance for eligible, commercially insured patients for co-pays, co-insurance, or deductibles incurred for the Product, up to $25,000 per calendar year. It does not cover or provide support for supplies, services, procedures, or any other physician-related services associated with the Product treatment.

For patients to be eligible for the IV Co-Pay Program, they must have commercial insurance that covers BESPONSA™ (inotuzumab ozogamicin) or MYLOTARG™ (gemtuzumab ozogamicin) (each referred to as “Product”) and they cannot be enrolled in a state or federally funded insurance program. Whether a co-pay expense is eligible for the IV Co-Pay Program benefit will be determined at the time the benefit is paid. Co-pay expenses must be in connection with a separately paid claim for Product administered in the outpatient setting.

#The IV Co-Pay Program will pay the co-pay and any deductible obligations for the Product up to the annual assistance limit of $25,000 per calendar year per patient.

Pfizer Oncology Together Co-Pay Savings Program for Injectables for ZIRABEV

The Pfizer Oncology Together Co-Pay Savings Program for Injectables for ZIRABEV can provide you with assistance for your out-of-pocket drug costs, including co-pays and coinsurance. Limits, terms, and conditions apply.

Apply Today

To apply, download the Pfizer Oncology Together enrollment form and fill out the required fields. This form requires some information from your healthcare provider, so it's best to fill it out together.

enrollment form

For eligible, commercially insured patients

You may pay as little as $0 for each ZIRABEV treatment. #

UP TO $25,000 PER CALENDAR YEAR

The program covers up to $25,000 per calendar year. **

No income requirements

There are no income requirements for you to qualify.

GET STARTED WITH FINANCIAL ASSISTANCE

If you have questions or would like to know more about the Pfizer Oncology Together Co-Pay Savings Program for Injectables for ZIRABEV, call us at 1-877-744-5675 (Monday–Friday 8 AM–8 PM ET).

The Pfizer Oncology Together Co-Pay Savings Program for lnjectables for ZIRABEV provides assistance for eligible, commercially insured patients for co-pays, co-insurance, or deductibles incurred for the Product, up to $25,000 per calendar year. It does not cover or provide support for supplies, services, procedures, or any other physician-related services associated with the Product treatment.

#For patients to be eligible for the Pfizer Oncology Together Co-Pay Savings Program for lnjectables for ZIRABEV, they must have commercial insurance that covers ZIRABEV™ (bevacizumab-bvzr) and they cannot be enrolled in a state or federally funded insurance program. Whether a co-pay expense is eligible for the Pfizer Oncology Together Co-Pay Savings Program for lnjectables for ZIRABEV benefit will be determined at the time the benefit is paid. Co-pay expenses must be in connection with a separately paid claim for Product administered in the outpatient setting.

**The Pfizer Oncology Together Co-Pay Savings Program for lnjectables for ZIRABEV will pay the co-pay and any deductible obligations for the Product up to the annual assistance limit of $25,000 per calendar year per patient.

Pfizer Oncology Together Co-Pay Savings Program for Injectables: ZIRABEV™ (bevacizumab-bvzr)

The Pfizer Oncology Together Co-Pay Savings Program for Injectables can provide eligible, commercially insured patients prescribed ZIRABEV with assistance for their out-of-pocket drug costs, including co-pays and coinsurance.

Limits, terms, and conditions apply. Patients prescribed ZIRABEV for certain conditions are not eligible for this co-pay savings program.

ELIGIBLE, COMMERCIALLY INSURED PATIENTS MAY PAY AS LITTLE AS $0 FOR each ZIRABEV TREATMENT#

  • This program covers up to $25,000 per calendar year**
  • There are no income requirements for patients to qualify

Apply Today

To apply, download the Pfizer Oncology Together enrollment form and fill out the required fields. This form requires some information from your healthcare provider, so it's best to fill it out together.

enrollment form

GET STARTED WITH FINANCIAL ASSISTANCE

If you have questions or would like to know more about the Pfizer Oncology Together Co-Pay Savings Program for Injectables,
call us at 1-877-744-5675 (Monday–Friday 8 AM–8 PM ET).

The Injectables Co-Pay Program for ZIRABEV provides assistance for eligible, commercially insured patients prescribed ZIRABEV™ (bevacizumab-bvzr) for co-pays or coinsurance incurred for ZIRABEV, up to $25,000 per calendar year. It does not cover or provide support for supplies, services, procedures, or any other physician-related services associated with ZIRABEV treatment.

#For patients to be eligible for the Injectables Co-Pay Program for ZIRABEV, they must have commercial insurance that covers ZIRABEV and they cannot be enrolled in a state or federally funded insurance program. Whether a co-pay expense is eligible for the Injectables Co-Pay Program for ZIRABEV benefit will be determined at the time the benefit is paid. Co-pay expenses must be in connection with a separately paid claim for ZIRABEV administered in the outpatient setting.

**The Injectables Co-Pay Program for ZIRABEV will pay the co-pay obligations for ZIRABEV up to the annual assistance limit of $25,000 per calendar year per patient.

Pfizer Oncology Together Co-Pay Savings Program for Injectables: RUXIENCE™ (rituximab-pvvr)

The Pfizer Oncology Together Co-Pay Savings Program for Injectables can provide eligible, commercially insured patients prescribed RUXIENCE with assistance for their out-of-pocket drug costs, including co-pays and coinsurance.

Limits, terms, and conditions apply. Patients prescribed RUXIENCE for certain conditions are not eligible for this co-pay savings program.

ELIGIBLE, COMMERCIALLY INSURED PATIENTS MAY PAY AS LITTLE AS $0 FOR each RUXIENCE TREATMENT#

  • This program covers up to $25,000 per calendar year**
  • There are no income requirements for patients to qualify

Apply Today

To apply, download the Pfizer Oncology Together enrollment form and fill out the required fields. This form requires some information from your healthcare provider, so it's best to fill it out together.

enrollment form

Please see RUXIENCE Medication Guide and full Prescribing Information, including BOXED WARNING, or visit RUXIENCE.com.

GET STARTED WITH FINANCIAL ASSISTANCE

If you have questions or would like to know more about the Pfizer Oncology Together Co-Pay Savings Program for Injectables,
call us at 1-877-744-5675 (Monday–Friday 8 AM–8 PM ET).

The Injectables Co-Pay Program for RUXIENCE provides assistance for eligible, commercially insured patients prescribed RUXIENCE™ (rituximab-pvvr) for co-pays or coinsurance incurred for RUXIENCE, up to $25,000 per calendar year. It does not cover or provide support for supplies, services, procedures, or any other physician-related services associated with RUXIENCE treatment.

#For patients to be eligible for the Injectables Co-Pay Program for RUXIENCE, they must have commercial insurance that covers RUXIENCE and they cannot be enrolled in a state or federally funded insurance program. Whether a co-pay expense is eligible for the Injectables Co-Pay Program for RUXIENCE benefit will be determined at the time the benefit is paid. Co-pay expenses must be in connection with a separately paid claim for RUXIENCE administered in the outpatient setting.

**The Injectables Co-Pay Program for RUXIENCE will pay the co-pay obligations for RUXIENCE up to the annual assistance limit of $25,000 per calendar year per patient.

Pfizer Oncology Together Co-Pay Savings Program for Injectables: TRAZIMERA™ (trastuzumab-qyyp)

The Pfizer Oncology Together Co-Pay Savings Program for Injectables can provide eligible, commercially insured patients prescribed TRAZIMERA with assistance for their out-of-pocket drug costs, including co-pays and coinsurance. Limits, terms, and conditions apply.

ELIGIBLE, COMMERCIALLY INSURED PATIENTS MAY PAY AS LITTLE AS $0 FOR each TRAZIMERA TREATMENT.#

  • This program covers up to $25,000 per calendar year**
  • There are no income requirements for patients to qualify

Apply Today

To apply, download the Pfizer Oncology Together enrollment form and fill out the required fields. This form requires some information from your healthcare provider, so it's best to fill it out together.

enrollment form

Please see TRAZIMERA full Prescribing Information, including BOXED WARNING, or visit TRAZIMERA.com.

GET STARTED WITH FINANCIAL ASSISTANCE

If you have questions or would like to know more about the Pfizer Oncology Together Co-Pay Savings Program for Injectables,
call us at 1-877-744-5675 (Monday–Friday 8 AM–8 PM ET).

The Injectables Co-Pay Program for TRAZIMERA provides assistance for eligible, commercially insured patients prescribed TRAZIMERA™ (trastuzumab-qyyp) for co-pays or coinsurance incurred for TRAZIMERA, up to $25,000 per calendar year. It does not cover or provide support for supplies, services, procedures, or any other physician-related services associated with TRAZIMERA treatment.

#For patients to be eligible for the Injectables Co-Pay Program for TRAZIMERA, they must have commercial insurance that covers TRAZIMERA and they cannot be enrolled in a state or federally funded insurance program. Whether a co-pay expense is eligible for the Injectables Co-Pay Program for TRAZIMERA benefit will be determined at the time the benefit is paid. Co-pay expenses must be in connection with a separately paid claim for TRAZIMERA administered in the outpatient setting.

**The Injectables Co-Pay Program for TRAZIMERA will pay the co-pay obligations for TRAZIMERA up to the annual assistance limit of $25,000 per calendar year per patient.

Pfizer Oncology Together Co-Pay Savings Program for Injectables: NIVESTYM® (filgrastim-aafi)

The Pfizer Oncology Together Co-Pay Savings Program for Injectables can provide eligible, commercially insured patients prescribed NIVESTYM with assistance for their out-of-pocket drug costs, including co-pays and coinsurance. Limits, terms, and conditions apply.

ELIGIBLE, COMMERCIALLY INSURED PATIENTS MAY PAY AS LITTLE AS $0 FOR EACH NIVESTYM TREATMENT#

  • This program covers up to $10,000 per calendar year**
  • There are no income requirements for patients to qualify

Apply Today

To apply, download the Pfizer Oncology Together enrollment form and fill out the required fields. This form requires some information from your healthcare provider, so it's best to fill it out together.

enrollment form

GET STARTED WITH FINANCIAL ASSISTANCE

If you have questions or would like to know more about the Pfizer Oncology Together Co-Pay Savings Program for Injectables,
call us at 1-877-744-5675 (Monday–Friday 8 AM–8 PM ET).

The Injectables Co-Pay Program for NIVESTYM provides assistance for eligible, commercially insured patients prescribed NIVESTYM® (filgrastim-aafi) for co-pays or coinsurance incurred for NIVESTYM, up to $10,000 per calendar year. It does not cover or provide support for supplies, services, procedures, or any other physician-related services associated with NIVESTYM treatment.

#For patients to be eligible for the Injectables Co-Pay Program for NIVESTYM, they must have commercial insurance that covers NIVESTYM and they cannot be enrolled in a state or federally funded insurance program. Whether a co-pay expense is eligible for the Injectables Co-Pay Program for NIVESTYM benefit will be determined at the time the benefit is paid. Co-pay expenses must be in connection with a separately paid claim for NIVESTYM administered in the outpatient setting.

**The Injectables Co-Pay Program for NIVESTYM will pay the co-pay obligations for NIVESTYM up to the annual assistance limit of $10,000 per calendar year per patient.

Pfizer Oncology Together Co-Pay Savings Program for Injectables: NIVESTYM™ (filgrastim-aafi)

The Pfizer Oncology Together Co-Pay Savings Program for Injectables can provide eligible, commercially insured patients prescribed NIVESTYM with assistance for their out-of-pocket drug costs, including co-pays and coinsurance. Limits, terms, and conditions apply.

Apply Today

To apply, download the Pfizer Oncology Together enrollment form and fill out the required fields. This form requires some information from your healthcare provider, so it's best to fill it out together.

enrollment form

For eligible, commercially insured patients

You may pay as little as $0 for each NIVESTYM treatment. #

UP TO $10,000 PER CALENDAR YEAR

The program covers up to $10,000 per calendar year. **

No income requirements

There are no income requirements for you to qualify.

GET STARTED WITH FINANCIAL ASSISTANCE

If you have questions or would like to know more about the Pfizer Oncology Together Co-Pay Savings Program for Injectables, call us at 1-877-744-5675 (Monday–Friday 8 am–8 pm ET).

The Injectables Co-Pay Program for NIVESTYM provides assistance for eligible, commercially insured patients prescribed NIVESTYM™ (filgrastim-aafi) for co-pays or coinsurance incurred for NIVESTYM, up to $10,000 per calendar year. It does not cover or provide support for supplies, services, procedures, or any other physician-related services associated with NIVESTYM treatment.

#For patients to be eligible for the Injectables Co-Pay Program for NIVESTYM, they must have commercial insurance that covers NIVESTYM and they cannot be enrolled in a state or federally funded insurance program. Whether a co-pay expense is eligible for the Injectables Co-Pay Program for NIVESTYM benefit will be determined at the time the benefit is paid. Co-pay expenses must be in connection with a separately paid claim for NIVESTYM administered in the outpatient setting.

**The Injectables Co-Pay Program for NIVESTYM will pay the co-pay obligations for NIVESTYM up to the annual assistance limit of $10,000 per calendar year per patient.

ADDITIONAL ASSISTANCE

We'll see if you're eligible for the Pfizer Patient Assistance Program, which can provide your prescribed Pfizer Oncology medicine for free.† Contact Pfizer Oncology Together for more information.

†The Pfizer Patient Assistance Program is a joint program of Pfizer Inc. and Pfizer Patient Assistance Foundation™. The Pfizer Patient Assistance Foundation is a separate legal entity from Pfizer Inc. with distinct legal restrictions.

BACK TO TOP